Sheridan Capital Partners

Healthcare-focused private equity firm

Growth/PE Growth/PE

AUM

Not Disclosed

Strategic / Balance-Sheet

PRIVATE

Sheridan Capital Partners is a healthcare-focused private equity firm. On October 7, 2026, Sheridan announced the closing of Sheridan Capital Partners Fund IV at its $1.1 billion hard cap with total institutional capital commitments, meaningfully oversubscribed and allocated in under 60 days. Concurrently Sheridan closed a complementary Healthcare IT Fund I at $245 million.

Firm Profile

Firm Type

Growth/PE

Subtype

Growth/PE

Country

USA

Active Fund

Sheridan Capital Partners Fund IV ($1.1B) · 2026

Notable Partners

Jonathan Lewis

Investment Focus

Stages

Growth · Buyout

Sectors

Healthcare

Growth/PEHealthcareDaily Discovery

Investor data reflects publicly disclosed AUM, fund sizes, and portfolio holdings as of 2026-10-07. Refreshed periodically.